SciELO - Scientific Electronic Library Online

 
vol.28 issue9Molecular pathology of sarcomasExtra-mammary signet-ring cell carcinoma after breast cancer: when are we dealing really with a second primary? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Oncología (Barcelona)

Print version ISSN 0378-4835

Abstract

SANCHEZ-MUNOZ, A. et al. Limitations to the use of serum tumor markers in oncologic practice. Oncología (Barc.) [online]. 2005, vol.28, n.9, pp.39-43. ISSN 0378-4835.

Serum tumor markers are often used for the evaluation of the response and follow-up of oncologic patiets after different dispensed therapies. We report three clinicl cases of false elevation of CA 15-3, CA 12-5 and CA 19-9 serum tumor markers during the follow-up of patients diagnosed and treated for breast cancer, ovarian cancer and colorectal cancer respectively. The limitations to their use in oncologic practice are discussed in relation with sensitivity and specificity problems, as well as their usefulness in the prognosis, survival and quality of life considerations of the patients.

Keywords : Serum tumor markers; Surveillance; Treatment monitoring.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License